RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Acorn Bioventures
A

Acorn Bioventures portfolio

Acorn Bioventures has 1 portfolio company on record at Recent Funding.

Website: acornbioventures.com.
Type: Crossover fund.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 0.
Capital in their rounds: $197M.
Latest deal: Neuron23 · Jun 24, 2025.
About this page

It is a crossover fund based in New York, US, founded in 2017. Its most recent investment on record is Neuron23's $97M Series B+ round in June 2025, alongside Redmile Group, Kleiner Perkins, SoftBank Vision Fund and 3 others. That company is in Health and bio. It has co-invested with Kleiner Perkins, SoftBank Vision Fund and Redmile Group, most often Kleiner Perkins (2 rounds).

About Acorn Bioventures

Firm type: Crossover fund.
Headquarters: New York, US.
Founded: 2017.
Stages: Seed, Series A, Series B, Series C, Growth, Late Stage.
Sectors: Biotech, Medical Devices.

What Acorn Bioventures invests in

How Acorn Bioventures invests

StageDealsCapital in rounds
Series B+ 2 100%$197M
YearDealsCapital in rounds
2022 1 50%$100M
2025 1 50%$97M

Acorn Bioventures portfolio companies

CompanyRound with Acorn BioventuresTotal raisedLatest raise
NNeuron23
Health and bio
 Series B+ · $97M$197MJun 24, 2025
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Share is of the 2 rounds on Recent Funding that name Acorn Bioventures. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Acorn Bioventures, which is a subset of its real portfolio. API: /api/v1/investors/acorn-bioventures (get a free API key). More: the most active VC firms and new venture capital funds.